Storia in 2 fonti

Lupin gets tentative US FDA nod for Enzalutamide tablets

Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo11 g fa

Lupin gets tentative US FDA nod for Enzalutamide tablets

Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.

originale

economictimes.indiatimes.com11 g fa

Lupin gets USFDA tentative approval for prostate cancer treatment drug

Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatment for advanced prostate cancer. This approval covers multiple strengths,…

Leggi questa versione → originale

Timeline cronologica

venerdì 26 giugno 2026·thehindubusinessline.com
Lupin gets tentative US FDA nod for Enzalutamide tablets
Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.
venerdì 26 giugno 2026·economictimes.indiatimes.com
Lupin gets USFDA tentative approval for prostate cancer treatment drug
Indian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatment for advanced prostate cancer. This…